(Q33180441)
Statements
1 reference
Phase I trial of the anti-Lewis Y drug immunoconjugate BR96-doxorubicin in patients with lewis Y-expressing epithelial tumors (English)
1 reference
M N Saleh
1 reference
S Sugarman
1 reference
J Murray
1 reference
J B Ostroff
1 reference
D Healey
1 reference
D Jones
1 reference
C R Daniel
1 reference
D LeBherz
1 reference
H Brewer
1 reference
N Onetto
1 reference
A F LoBuglio
1 reference
1 June 2000
1 reference
1 reference
18
1 reference
11
1 reference
2282-2292
1 reference
Identifiers
1 reference
1 reference